Black Rock Inc. Gelesis Holdings, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.11 - $0.52 $10,008 - $47,312	-90,985 Reduced 11.39%	708,171 $113,000
Q4 2022 Feb 13, 2023	BUY	$0.22 - $0.51 $5,522 - $12,803	25,104 Added 3.24%	799,156 $231,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.34 $15,523 - $260,017	194,043 Added 33.46%	774,052 $835,000
Q2 2022 Aug 12, 2022	BUY	N/A	296,540 Added 104.61%	580,009 $900,000
Q1 2022 May 12, 2022	BUY	N/A	283,469 New	283,469 $1.28 Million

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.